101
Participants
Start Date
February 29, 2012
Primary Completion Date
September 30, 2013
Study Completion Date
December 31, 2013
Diabetes medication management
As above plus- Follow-up intervention visits were at 24-72 hrs, 2 and 4 weeks. During each, further DSME was provided, BG logs reviewed, and diabetes medications adjusted as needed by the CDE. Meter and insulin injections skills were reinforced as needed. Outpatient navigation included securing a primary care appointment no later than 4 weeks after study completion. Final contact was via telephone at 90 days. The MMS© (Morisky Medication Adherence Survey) was taken at 2 and 4 weeks and during the final telephone visit. Interim return visits to the ED or admissions to the hospital were queried at each visit. A follow up HbA1C was obtained at week 4 using the POC A1CNow+ ®, and a venous HbA1C was drawn if the POC result was above 13% .
MedStar Washington Hospital Center, Washington D.C.
Lead Sponsor
American Diabetes Association
OTHER
Sanofi
INDUSTRY
Bayer
INDUSTRY
Medstar Health Research Institute
OTHER